# Crinetics Pharmaceuticals, Inc. (CRNX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Crinetics Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CRNX/mda/fy2025/): filed 2026-02-26; accession 0001658247-26-000012 (https://www.sec.gov/Archives/edgar/data/1658247/000165824726000012/crnx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/CRNX/mda/fy2024/): filed 2025-02-27; accession 0000950170-25-029050 (https://www.sec.gov/Archives/edgar/data/1658247/000095017025029050/crnx-20241231.htm)
- [FY 2023 MD&A](/company/CRNX/mda/fy2023/): filed 2024-02-28; accession 0000950170-24-022108 (https://www.sec.gov/Archives/edgar/data/1658247/000095017024022108/crnx-20231231.htm)
- [FY 2022 MD&A](/company/CRNX/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-005132 (https://www.sec.gov/Archives/edgar/data/1658247/000095017023005132/crnx-20221231.htm)
- [FY 2021 MD&A](/company/CRNX/mda/fy2021/): filed 2022-03-30; accession 0000950170-22-005050 (https://www.sec.gov/Archives/edgar/data/1658247/000095017022005050/crnx-20211231.htm)

Back to /company/CRNX/